Fcf Advisors LLC Lantheus Holdings, Inc. Transaction History

Fcf Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$51.07 - $68.26 $617,589 - $825,468	-12,093 Reduced 74.06%	4,235 $263,000
Q4 2023 Jan 04, 2024	BUY	$55.6 - $77.89 $498,509 - $698,361	8,966 Added 121.79%	16,328 $1.01 Million
Q3 2023 Oct 10, 2023	SELL	$60.27 - $90.75 $113,488 - $170,882	-1,883 Reduced 20.37%	7,362 $511,000
Q2 2023 Jul 19, 2023	SELL	$82.41 - $99.65 $4,944 - $5,979	-60 Reduced 0.64%	9,245 $775,000
Q1 2023 Apr 19, 2023	BUY	$47.76 - $82.86 $444,406 - $771,012	9,305 New	9,305 $768,000

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.08B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Fcf Advisors LLC with notifications on news.